Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Intersect Ent Inc (XENT)

Intersect Ent Inc (XENT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 676,942
  • Shares Outstanding, K 31,515
  • Annual Sales, $ 108,470 K
  • Annual Income, $ -22,920 K
  • 60-Month Beta 0.78
  • Price/Sales 6.08
  • Price/Cash Flow N/A
  • Price/Book 5.93

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.33
  • Number of Estimates 5
  • High Estimate -0.27
  • Low Estimate -0.37
  • Prior Year -0.16
  • Growth Rate Est. (year over year) -106.25%

Price Performance

See More
Period Period Low Period High Performance
1-Month
20.49 +4.83%
on 11/13/19
22.19 -3.20%
on 11/27/19
+0.59 (+2.82%)
since 11/12/19
3-Month
14.61 +46.97%
on 10/07/19
22.95 -6.41%
on 11/01/19
+3.62 (+20.27%)
since 09/12/19
52-Week
14.61 +46.97%
on 10/07/19
35.87 -40.12%
on 02/26/19
-10.55 (-32.94%)
since 12/12/18

Most Recent Stories

More News
Intersect ENT (XENT) Grows on Innovation Despite Cost Woes

The latest offering in Intersect ENT's (XENT) SINUVA portfolio is specific J code - J7401.

XENT : 21.48 (+2.73%)
NUVA : 73.85 (+0.09%)
RMD : 152.25 (+1.18%)
HAE : 117.17 (-0.32%)
Intersect ENT to Present at the 38th Annual J.P. Morgan Healthcare Conference

Intersect ENT, Inc. (Nasdaq: XENT), today announced that management will participate in the 38th Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2020 at the Westin St. Francis Hotel...

JPM : 138.75 (+0.53%)
XENT : 21.48 (+2.73%)
SI-BONE Names Jeryl ("Jeri") Hilleman to Board of Directors

SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that Jeri Hilleman has joined its...

SIBN : 19.06 (+3.59%)
NVCR : 77.84 (-1.34%)
NERV : 7.55 (+0.94%)
XENT : 21.48 (+2.73%)
AMRS : 3.50 (+0.14%)
Why Is Intersect ENT (XENT) Up 21.7% Since Last Earnings Report?

Intersect ENT (XENT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

XENT : 21.48 (+2.73%)
Intersect ENT Announces Appointment of New Chief Financial Officer

Intersect ENT(R), Inc. (NASDAQ:XENT), a company dedicated to transforming care for patients with ear, nose and throat conditions, today announced the appointment of Richard A. (Randy) Meier as Executive...

ABT : 85.97 (+1.25%)
OMI : 6.15 (-13.14%)
XENT : 21.48 (+2.73%)
BMRN : 80.90 (+2.70%)
Intersect ENT to Present at the 31st Annual Piper Jaffray Healthcare Conference

Intersect ENT, Inc. (NASDAQ: XENT) today announced that management will participate in the 31st Annual Piper Jaffray Healthcare Conference on December 4 at the Lotte New York Palace Hotel in New York City,...

XENT : 21.48 (+2.73%)
Best Relative Performance in the Pharmaceuticals Industry Detected in Shares of Nektar Therapeut (NKTR , XENT , AERI , MYL , AGN )

Here are the top 5 stocks in the Pharmaceuticals industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

AERI : 22.10 (+3.08%)
XENT : 21.48 (+2.73%)
NKTR : 21.79 (+0.88%)
Intersect ENT (XENT) Reports Q3 Loss, Revenues Meet Estimates

Intersect ENT (XENT) exhibits a dismal performance in the third quarter of 2019.

TMO : 321.00 (+0.51%)
XENT : 21.48 (+2.73%)
RMD : 152.25 (+1.18%)
NUVA : 73.85 (+0.09%)
Look for Shares of Intersect Ent In to Potentially Pullback after Yesterday's 23.63% Rise

Intersect Ent In (NASDAQ:XENT) traded in a range yesterday that spanned from a low of $18.18 to a high of $22.75. Yesterday, the shares gained 23.6%, which took the trading range above the 3-day high...

XENT : 21.48 (+2.73%)
Intersect ENT (XENT) Reports Q3 Loss, Lags Revenue Estimates

Intersect ENT (XENT) delivered earnings and revenue surprises of -2.50% and -0.73%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

XENT : 21.48 (+2.73%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Average short term outlook on maintaining the current direction.

See More Share

Trade XENT with:

Business Summary

Intersect ENT, Inc. is a commercial drug-device company. The Company's initial products, PROPEL and PROPEL mini, are drug-eluting implants for use in patients with chronic sinusitis. It offers products and therapies for ear, nose, and throat surgeons to improve treatment for their patients with chronic...

See More

Key Turning Points

2nd Resistance Point 22.11
1st Resistance Point 21.79
Last Price 21.48
1st Support Level 20.90
2nd Support Level 20.33

See More

52-Week High 35.87
Fibonacci 61.8% 27.75
Fibonacci 50% 25.24
Fibonacci 38.2% 22.73
Last Price 21.48
52-Week Low 14.61

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar